PDS Biotechnology Corporation
News
PDS Biotech to Present Updated VERSATILE-002 Data at ESMO Congress 2024
Globe Newswire Presentation of data will take place on Saturday, September 14, 2024PRINCETON, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) ( PDS Biotech or the Company...\n more…
PDS Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference
Globe Newswire PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) ( PDS Biotech or the Company ), a late-stage immunotherapy company focused on transforming how the...\n more…
Analysts Set PDS Biotechnology Co. (NASDAQ:PDSB) PT at $14.25
Ticker Report PDS Biotechnology Co. (NASDAQ:PDSB - Get Free Report) has received an average rating of "Buy" from the five ratings firms that are presently covering the firm, Marketbeat reports. Four equities...\n more…
Alliance Global Partners Upgrades PDS Biotechnology (NASDAQ:PDSB) to Strong-Buy
Ticker Report PDS Biotechnology (NASDAQ:PDSB - Get Free Report) was upgraded by analysts at Alliance Global Partners to a "strong-buy" rating in a report released on Wednesday, Zacks.com reports. Several other...\n more…
Alliance Global Partners Increases PDS Biotechnology (NASDAQ:PDSB) Price Target to $7.00
Ticker Report PDS Biotechnology (NASDAQ:PDSB - Get Free Report) had its price objective upped by research analysts at Alliance Global Partners from $5.00 to $7.00 in a research note issued to investors on Tuesday...\n more…
